Articles: professional-practice.
-
Contact lens practice is the leading source of liability claims involving optometrists. Claims most often allege negligence, although informed consent or product liability may also be causes of legal claims for damages. For daily wear patients, the most likely causes of claims are nonapproved use of lenses or solutions, monovision contact lenses, negligence by a contact lens technician, failure to verify lenses before dispensing, mismanagement of contact lens-related corneal abrasions, and inadequate monitoring of ocular health. For extended-wear patients, the most common sources of liability claims are inappropriate patient selection, inadequate training of patients, improper wearing schedules, improper management of contact lens-related corneal complications, and inadequate monitoring of ocular health.
-
A survey of recent family medicine graduates showed that two thirds were doing no emergency work. Those who had originally planned to practise emergency medicine were more likely to be doing it than those who had not. More women than men dropped their plans to do emergency work. Two thirds of those who had dropped their plans thought their training had influenced the decision.
-
Two key factors are of main importance for the development of a common GCP legislation in the Member States of the European Community: 1) July 1991, Enforcement of the EEC Note for Guidance: "Good Clinical Practice for Trials on Medicinal Products in the European Community". This enforcement was setting into operation GCP guidelines which were, however, not yet legally binding at that time. 2) January 1992, Enforcement of EEC Commission, Directive 91/507/EEC: Analytical, pharmacotoxicological and clinical standards and protocols in respect of the testing of medicinal products. By this enforcement the EEC Member States were obliged to bring into force the laws, regulations and administrative provisions necessary to comply with the Directive which requests--besides others--all clinical trials to be designed, implemented and recorded in accordance with GCP. ⋯ Country by country this has to be regulated soon by appropriate measures of the legislators in order to establish a uniform standard which will assure clinical trials to be internationally acceptable. Only recently the CPMP introduced the requirement for a "Compliance with GCP" Statement as an indispensable part of the Clinical Expert Reports in registration documentations. Even more than in legislation, there is a lack of inspections in clinical trials by health authorities in most European countries.(ABSTRACT TRUNCATED AT 250 WORDS)